JOINN Laboratories (China) Co., Ltd. has released the Terms of Reference for its newly established Strategic Development Committee. According to the document, the committee is set up under the Board of Directors to further enhance the company’s strategic planning, improve investment decision-making procedures, and strengthen corporate governance.

The committee will comprise four directors, including at least one independent director. Its chairperson will also serve as the committee's convener, overseeing the study and recommendations on the company’s long-term strategic development plans, major investments, and financing proposals. A dedicated investment review team, headed by the general manager, will handle preliminary reviews and provide relevant materials for proposals submitted to the committee.

The document details the committee’s major responsibilities, which include reviewing significant capital operations and asset-related projects that require Board approval, as stipulated in the Articles of Association or as authorized by the general meeting. The Strategic Development Committee will hold meetings based on the submitted proposals, with the resulting decisions and discussion outcomes reported to the Board of Directors.

To assist in decision-making, external professionals may be engaged when deemed necessary, and any expenses incurred will be borne by the company. The Terms of Reference also cover meeting procedures, voting rules, and the requirements for detailed meeting minutes, ensuring transparency and accountability in the committee’s operations. The new terms take effect from the date of the relevant Board resolution approval.